Dimestrol
Estrogen ether | |
Identifiers | |
---|---|
| |
JSmol) | |
| |
|
Dimestrol (brand names Depot-Cyren, Depot-Oestromon), also known as dianisylhexene, 4,4'-dimethoxy-α,α'-diethylstilbene, diethylstilbestrol dimethyl ether, and dimethoxydiethylstilbestrol, is a
DES is a known endocrine disrupting chemical. Molecularly, it is known to increase the risk of aneuploidy via interference with microtubule assembly.[6]
Prior to the 1950s, DES was widely prescribed to pregnant women to prevent miscarriage and preterm labor. A study released in the 1950s found that women who were exposed to DES were at increased risk for cervical and vaginal clear cell adenocarcinoma. Shortly after this finding, the FDA discouraged the prescription of DES to pregnant women. Children were also affected by the maternal use of DES during their gestation. Study findings showed that daughters were more likely to develop fertility complications such as premature delivery, neonatal death, miscarriage, ectopic pregnancy, stillbirth, infertility, and preeclampsia. DES exposed sons may also experience genital abnormalities but no conclusive increased risk of infertility.[7]
In the case of suspected or known exposure to DES before, women are encouraged to receive pelvic examinations, PAP tests, biopsies, and breast examinations. Men should receive routine examinations from their physician in the case of suspected or potential exposure.[7]
The medication has a long
Estrogen | Form | Major brand name(s) | EPD (14 days) | Duration | |
---|---|---|---|---|---|
Diethylstilbestrol (DES) | Oil solution | Metestrol | 20 mg | 1 mg ≈ 2–3 days; 3 mg ≈ 3 days | |
Diethylstilbestrol dipropionate | Oil solution | Cyren B | 12.5–15 mg | 2.5 mg ≈ 5 days | |
Aqueous suspension | ? | 5 mg | ? mg = 21–28 days | ||
Dimestrol (DES dimethyl ether) | Oil solution | Depot-Cyren, Depot-Oestromon, Retalon Retard | 20–40 mg | ? | |
Fosfestrol (DES diphosphate)a | Aqueous solution | Honvan | ? | <1 day | |
Dienestrol diacetate | Aqueous suspension | Farmacyrol-Kristallsuspension | 50 mg | ? | |
Hexestrol dipropionate | Oil solution | Hormoestrol, Retalon Oleosum | 25 mg | ? | |
Hexestrol diphosphatea | Aqueous solution | Cytostesin, Pharmestrin, Retalon Aquosum | ? | Very short | |
Note: All by intravenous injection . Sources: See template.
|
See also
References
- ISBN 978-1-4757-2085-3.
- ISBN 978-0-8155-1856-3.
- ^ Soviet Genetics. Consultants Bureau. 1982.
- ISBN 9780598358813. NAP:14582.
- ^ "Diethylstilbestrol". MeSH. NCBI.
- PMID 1861692.
- ^ a b "Diethylstilbestrol (DES) and Cancer". 2011-10-05.
- ISBN 978-3-7091-5694-0.